HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masatoshi Kadoya Selected Research

Carcinoma (Carcinomatosis)

5/2015Pigment epithelium-derived factor inhibits the growth of human esophageal squamous cell carcinoma by suppressing neovascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masatoshi Kadoya Research Topics

Disease

4Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
12/2023 - 01/2022
4Rheumatoid Arthritis
03/2011 - 01/2008
3Infections
04/2024 - 01/2020
3Inflammation (Inflammations)
11/2020 - 09/2010
3Neoplasms (Cancer)
09/2006 - 06/2003
2Vasculitis (Vasculitides)
12/2023 - 01/2023
2Fibrosis (Cirrhosis)
01/2014 - 03/2011
1Renal Insufficiency (Renal Failure)
04/2024
1Microscopic Polyangiitis
04/2024
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
04/2024
1Dementia (Dementias)
07/2022
1Uveitis
07/2022
1Scleritis (Episcleritis)
07/2022
1Immunoglobulin G4-Related Disease
07/2022
1Meningitis
01/2022
1Eosinophilia
09/2021
1Mononeuropathies (Mononeuritis Multiplex)
09/2021
1Edema (Dropsy)
11/2020
1Amyloidosis
11/2020
1Chronic Renal Insufficiency
11/2020
1Arthralgia (Joint Pain)
11/2020
1Pain (Aches)
11/2020
1Tenosynovitis
11/2020
1Synovitis
11/2020
1Suppuration
01/2020
1Carcinoma (Carcinomatosis)
05/2015
1Esophageal Squamous Cell Carcinoma
05/2015
1Neurologic Manifestations (Neurological Manifestations)
01/2015
1Guillain-Barre Syndrome
01/2015
1Albuminuria
01/2015
1Pneumonia (Pneumonitis)
01/2014
1Body Weight (Weight, Body)
01/2014
1Lung Injury
01/2014
1Lung Neoplasms (Lung Cancer)
10/2011
1Atherosclerosis
09/2010
1Osteoporosis
01/2008
1Lupus Nephritis
01/2008
1Bone Resorption
01/2008
1Aneurysm (Aneurysms)
06/2007
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2005
1Adenocarcinoma
12/2005
1Neoplasm Metastasis (Metastasis)
06/2003
1Disseminated Intravascular Coagulation
06/2003
1Stomach Neoplasms (Stomach Cancer)
06/2003

Drug/Important Bio-Agent (IBA)

4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2023 - 09/2021
3SteroidsIBA
07/2022 - 01/2008
2Immunoglobulin G (IgG)IBA
12/2023 - 07/2022
2pigment epithelium-derived factorIBA
05/2015 - 12/2005
2Interleukin-6 (Interleukin 6)IBA
03/2011 - 03/2011
1MethylprednisoloneFDA LinkGeneric
04/2024
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2023
1cyclic citrullinated peptideIBA
11/2020
1Rheumatoid FactorIBA
11/2020
1Prednisolone (Predate)FDA LinkGeneric
11/2020
1AcidsIBA
01/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2015
1indium-bleomycinIBA
01/2014
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2014
1Sphingosine-1-Phosphate ReceptorsIBA
01/2014
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2011
1MucinsIBA
03/2011
1CytokinesIBA
03/2011
1SodiumIBA
09/2010
1loxoprofen (CS 600)IBA
09/2010
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2010
1Eicosapentaenoic AcidIBA
09/2008
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2008
1mizoribineIBA
01/2008
1InterleukinsIBA
01/2008
1Interleukin-1 (Interleukin 1)IBA
01/2008
1Prostaglandins EIBA
01/2008
1ProstaglandinsIBA
01/2008
1Dopamine (Intropin)FDA LinkGeneric
09/2006
1Dopamine Receptors (Dopamine Receptor)IBA
09/2006
1Therapeutic UsesIBA
12/2005
1Dacarbazine (DIC)FDA LinkGeneric
06/2003
1titanium silicide (TS-1)IBA
06/2003

Therapy/Procedure

6Therapeutics
12/2023 - 12/2005
3Aftercare (After-Treatment)
04/2024 - 12/2005
2Remission Induction
12/2023 - 10/2023
1Renal Dialysis (Hemodialysis)
11/2020
1Debridement
01/2020
1Intravenous Administration
01/2015
1Operative Surgical Procedures
10/2011
1Laparotomy
06/2007
1Oral Administration
06/2003